“We believe the strong patient protections in Part D will help everyone get access to the drugs that are right for them at a lower cost,” Mr Azar said during a recent speech, “but we want your input on how that should work.”
HIV-negative men who receive pre-exposure prophylaxis with tenofovir and emtricitabine do not develop resistance to these drugs, according to new findings.
Researchers have discovered special proteins found in a small portion of HIV-infected individuals that could be the key to an HIV vaccine.
An intervention focusing on systems navigation, psychosocial counseling, and antiretroviral therapy at any CD4 count improves outcomes among HIV-infected people who inject drugs, according to a new study in The Lancet.
According to a recent study, rates of viral suppression nearly tripled among US residents living with HIV between 1997 and 2015.